NCT05991102View on ClinicalTrials.gov

Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With TAS-102 (Lonsurf) and Bevacizumab in Refractory Metastatic Colorectal Cancer

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Refractory Metastatic Colorectal Cancer
Interventions
DEVICE

Radiofrequency electromagnetic field treatment

Radiofrequency electromagnetic field treatment using a carrier frequency of 13.56 MHz

Trial Locations (1)

13353

RECRUITING

Charité Universitätsmedizin Berlin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER